Pharmacyclics lymphoma drug shows continued promise

Published June 10, 2010

Pharmacyclics lymphoma drug shows continued promise
CHICAGO (Reuters) – The latest results from a small, early stage trial of Pharmacyclics Inc’s experimental drug for non-Hodgkin’s lymphoma showed about 49 percent of patients responded to it, the company said on Saturday.